WALDENSTRÖM MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Oral drug combo tested for rare blood cancer
Disease control CompletedThis study tested whether a combination of oral medications could help control Waldenström macroglobulinemia, a rare blood cancer. The treatment involved initial therapy with thalidomide, cyclophosphamide, and dexamethasone, followed by long-term maintenance therapy with thalidom…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Oral drug combo aims for deep remission in rare blood cancer
Disease control CompletedThis study tested a combination of three oral drugs—zanubrutinib, ixazomib, and dexamethasone—for people newly diagnosed with symptomatic Waldenström macroglobulinemia, a rare blood cancer. The treatment was given for up to two years and then stopped to see if the response lasted…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Chinese trial tests two drug cocktails for rare blood cancer
Disease control CompletedThis study compared two different drug combinations for people newly diagnosed with Waldenström macroglobulinemia, a rare blood cancer. Thirty-five patients in China received either a rituximab-based regimen or a bortezomib-based regimen, along with two other standard drugs. The …
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Trial tests aggressive stem cell treatment for rare blood cancer
Disease control CompletedThis study aimed to see if a patient's own stem cells, collected and transplanted back after high-dose chemotherapy, works better than standard chemotherapy alone for people with high-risk Waldenström macroglobulinemia, a rare blood cancer. It involved 70 patients in China who ha…
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Early trial tests new combo for tough blood cancers
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of combining two drugs, acalabrutinib and pembrolizumab, for people with various blood cancers. It involved 161 participants with conditions like lymphoma and leukemia. The main goal was to see if the combination …
Matched conditions: WALDENSTRÖM MACROGLOBULINEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC